Dr de Azambuja talks with ecancer at the ESMO 2017 Congress about the data presented by Dr Angelo Di Leo from the MONARCH 3 trial looking at abemaciclib as initial therapy for patients with HR /HER2- advanced breast cancer. For more information...
from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2wi1dac
via IFTTT
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Αρχειοθήκη ιστολογίου
-
►
2023
(272)
- ► Φεβρουαρίου (141)
- ► Ιανουαρίου (131)
-
►
2022
(2066)
- ► Δεκεμβρίου (80)
- ► Σεπτεμβρίου (170)
- ► Φεβρουαρίου (190)
- ► Ιανουαρίου (203)
-
►
2021
(7399)
- ► Δεκεμβρίου (186)
- ► Σεπτεμβρίου (472)
- ► Φεβρουαρίου (851)
-
►
2020
(2517)
- ► Δεκεμβρίου (792)
- ► Σεπτεμβρίου (21)
- ► Φεβρουαρίου (28)
-
►
2019
(12076)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (4765)
- ► Ιανουαρίου (5155)
-
►
2018
(3144)
- ► Δεκεμβρίου (3144)
-
▼
2017
(66935)
- ► Δεκεμβρίου (1995)
-
▼
Σεπτεμβρίου
(12424)
-
▼
Σεπ 10
(264)
- Comparative SEM analysis of nine F22 aligner clean...
- Collagen Membrane Over Buccal Fat Pad Versus Bucca...
- Collagen Membrane Over Buccal Fat Pad Versus Bucca...
- University of Maryland, Catholic Charities offer f...
- Issue Information - TOC
- Continuing Professional Development Quiz
- Issue Information - JEB
- The use of mobile health applications in school de...
- Continuing Professional Development Calendar
- Personalized/Precision Dentistry – The Future of D...
- ESMO 2017: Combination targeted adjuvant therapy d...
- ESMO 2017: KEYNOTE-040 evaluates pembrolizumab in ...
- ESMO 2017: Adjuvant nivolumab superior to ipilimum...
- ESMO 2017: Updated results of the SCOT study
- Impacted canines: localisation with conventional o...
- Leaching variations of heavy metals in chelator-as...
- Acne Scars: How Do We Grade Them?
- Doctors should buckle up for health reforms: Barre...
- The quadruple burden of sepsis [Commentary]
- Sepsis, one of CMAJs four new areas of focus [Edit...
- Duration of antiresorptive activity of zoledronate...
- Health leaders must share the reins of reform: out...
- Recommendations on screening for abdominal aortic ...
- Physicians debate tax reforms at CMA annual meetin...
- Superimposed lateralized exanthem in a 30-year-old...
- Lively debate on disability insurance for medical ...
- Physicians and regionalization in Canada: past, pr...
- Physicians support assisted death for mature minor...
- Canadian hepatitis C virus screening guideline: a ...
- Doctors and health funding must focus on most vuln...
- Extrapolation warning [Letters]
- Doctors dissect medicines bullying problem [News]
- How physicians can "flex their advocacy muscles" [...
- Focus on patients, the rest will follow, says new ...
- CMA votes for review of medical liability system [...
- Healthier doctors means healthier patients: CMA pr...
- Anophthalmia
- IJMS, Vol. 18, Pages 1941: The ABCC6 Transporter: ...
- Helicobacter pylori infection and extragastric dis...
- Genomics of Helicobacter pylori
- Gastric cancer: Basic aspects
- Other Helicobacters, gastric and gut microbiota
- Diagnosis of Helicobacter pylori infection
- Helicobacter: Inflammation, immunology and vaccines
- Abstracts
- Keyword Index
- Pathogenesis of Helicobacter pylori infection
- Treatment of Helicobacter pylori infection 2017
- Epidemiology of Helicobacter pylori infection
- Helicobacter pylori, gastric cancer and other gast...
- Issue Information
- Helicobacter pylori infection in children
- 30th anniversary of the European helicobacter & mi...
- Author Index
- Helicobacter pylori infection and nonmalignant dis...
- Intralesional excision combined with intralesional...
- A disease-associated mutation in the adhesion GPCR...
- Adenocarcinoma of the lacrimal gland: a case report
- Organic acids as a freshness indicator for tofu (s...
- Rapid test for the determination of total phenolic...
- Development of high protein, high fiber smoothie a...
- Use of TPP and ATPS for partitioning and recovery ...
- Extraction, characterization and bioactive propert...
- Characteristics of patients with sorafenib-treated...
- Genetic variation in the Vitamin D related pathway...
- Identifying actionable variants using next generat...
- Brucellosis in livestock and wildlife: zoonotic di...
- Effect of hydrophobicity of pharmaceuticals and pe...
- Association between maternal nonresponsive feeding...
- Dental Teambuilding Expert Kevin Henry: 5 Ways Den...
- New Dandelion Algorithm Optimizes Extreme Learning...
- Optical and Magnetic Properties of Ni Doped ZnS Di...
- Control for MJLS with Infinite Markov Chain
- Free Vibration Analysis of the Unified Functionall...
- ESMO 2017: FOLFOX4/XELOX in stage II–III colon can...
- ESMO 2017: Efficacy of 3 versus 6 months of oxalip...
- ESMO 2017: Three versus six months’ adjuvant oxali...
- Clinicopathological parameters affecting nodal yie...
- Clinicopathological parameters affecting nodal yie...
- A growing number of patients bring challenges for ...
- ESMO 2017: Combined lenvatinib and pembrolizumab p...
- Global analysis of membrane-associated protein oli...
- With immigration program in peril, tension high fo...
- Ligand-dependent Hedgehog pathway activation in Rh...
- Presurgical weight loss affects tumour traits and ...
- Aldehyde dehydrogenase 1B1: a novel immunohistolog...
- A novel inhibitory anti-invasive MAb isolated usin...
- HPV-positive women with normal cytology remain at ...
- A phase I/II study of KW-2478, an Hsp90 inhibitor,...
- SKLB188 inhibits the growth of head and neck squam...
- The association between fasting blood glucose and ...
- Anti-Mullerian hormone and endometrial cancer: a m...
- Ffar2 expression regulates leukaemic cell growth i...
- RT @neerajaiims : PFS with Ipi/nivo vs sunitinib b...
- Cytotoxicity and potential anti-inflammatory activ...
- ESMO 2017: Combined lenvatinib and everolimus prod...
- The role of tumour marker testing in early diagnosis
- ESMO 2017: Prostate cancer highlights
- Patient perceptions of chemotherapy side effects d...
- Comment: MONARCH 3 trial: Abemaciclib for advanced...
-
▼
Σεπ 10
(264)
Ετικέτες
Πληροφορίες
Κυριακή 10 Σεπτεμβρίου 2017
Comment: MONARCH 3 trial: Abemaciclib for advanced breast cancer
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Αναζήτηση αυτού του ιστολογίου
! # Ola via Alexandros G.Sfakianakis on Inoreader
-
Publication date: 1 May 2019 Source: Talanta, Volume 196 Author(s): Ruiqing Long, Te Li, Chaoying Tong, Lihui Wu, Shuyun Shi Abstract...
-
Oral Cancer Rapid Test Kit Market Rugged Expansion Foreseen by 2024 MilTech Oral cancer is one of the largest group of cancers ...
-
Related Articles SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,